AstraZeneca (AZN) Ratios

912 Followers

AstraZeneca Ratios

GB:AZN's free cash flow for Q4 2025 was $0.80. For the 2025 fiscal year, GB:AZN's free cash flow was decreased by $ and operating cash flow was $0.20. See a summary of the company’s cash flow.

Ratios	TTM	Dec 25	Dec 24	Dec 23	Dec 22
Liquidity Ratios
Current Ratio	0.94	0.94	0.93	0.81	0.86
Quick Ratio	0.72	0.72	0.74	0.64	0.68
Cash Ratio	0.19	0.19	0.20	0.19	0.23
Solvency Ratio	0.25	0.24	0.19	0.18	0.14
Operating Cash Flow Ratio	0.48	0.48	0.43	0.34	0.37
Short-Term Operating Cash Flow Coverage	4.70	4.70	5.50	2.11	1.88
Net Current Asset Value	$ -36.63B	$ -36.63B	$ -37.36B	$ -37.11B	$ -36.83B
Leverage Ratios
Debt-to-Assets Ratio	0.26	0.26	0.29	0.28	0.30
Debt-to-Equity Ratio	0.61	0.61	0.74	0.73	0.79
Debt-to-Capital Ratio	0.38	0.38	0.42	0.42	0.44
Long-Term Debt-to-Capital Ratio	0.34	0.34	0.39	0.36	0.38
Financial Leverage Ratio	2.34	2.34	2.55	2.58	2.61
Debt Service Coverage Ratio	3.76	3.68	3.76	2.02	1.54
Interest Coverage Ratio	8.43	8.11	9.19	8.31	5.69
Debt to Market Cap	0.09	0.10	0.14	0.13	0.13
Interest Debt Per Share	20.16	20.20	20.31	18.92	19.40
Net Debt to EBITDA	1.19	1.21	1.66	1.71	2.66
Profitability Margins
Gross Profit Margin	78.23%	81.90%	74.98%	73.95%	63.36%
EBIT Margin	23.93%	24.00%	18.70%	17.56%	7.65%
EBITDA Margin	33.69%	33.76%	28.06%	28.33%	19.50%
Operating Profit Margin	23.28%	23.40%	23.65%	20.54%	11.41%
Pretax Profit Margin	21.14%	21.11%	16.07%	15.06%	5.64%
Net Profit Margin	17.43%	17.41%	13.01%	13.00%	7.41%
Continuous Operations Profit Margin	17.44%	17.42%	13.02%	13.01%	7.42%
Net Income Per EBT	82.44%	82.45%	80.95%	86.32%	131.47%
EBT Per EBIT	90.82%	90.24%	67.96%	73.31%	49.43%
Return on Assets (ROA)	9.09%	8.96%	6.62%	5.99%	3.40%
Return on Equity (ROE)	23.00%	21.01%	16.89%	15.47%	8.86%
Return on Capital Employed (ROCE)	16.60%	16.47%	16.44%	13.56%	7.19%
Return on Invested Capital (ROIC)	13.14%	13.04%	12.90%	10.94%	6.67%
Return on Tangible Assets	18.86%	18.60%	15.03%	14.09%	8.78%
Earnings Yield	3.28%	3.56%	3.39%	2.87%	1.56%
Efficiency Ratios
Receivables Turnover	3.92	3.59	4.05	3.94	4.81
Payables Turnover	0.51	0.42	3.64	3.71	6.36
Inventory Turnover	1.98	1.62	2.51	2.26	3.45
Fixed Asset Turnover	4.05	4.00	4.55	4.44	4.68
Asset Turnover	0.52	0.51	0.51	0.46	0.46
Working Capital Turnover Ratio	-19.81	-29.67	-13.64	-9.91	-563.30
Cash Conversion Cycle	-434.51	-541.16	135.45	156.22	124.19
Days of Sales Outstanding	93.11	101.54	90.18	92.72	75.82
Days of Inventory Outstanding	184.78	225.08	145.57	161.76	105.79
Days of Payables Outstanding	712.40	867.79	100.31	98.26	57.41
Operating Cycle	277.89	326.62	235.75	254.49	181.60
Cash Flow Ratios
Operating Cash Flow Per Share	9.40	9.40	7.65	6.62	6.34
Free Cash Flow Per Share	6.61	5.59	4.69	4.20	4.68
CapEx Per Share	2.79	3.81	2.96	2.42	1.66
Free Cash Flow to Operating Cash Flow	0.70	0.59	0.61	0.63	0.74
Dividend Paid and CapEx Coverage Ratio	1.57	1.34	1.29	1.25	1.41
Capital Expenditure Coverage Ratio	3.37	2.47	2.59	2.74	3.81
Operating Cash Flow Coverage Ratio	0.49	0.49	0.39	0.36	0.34
Operating Cash Flow to Sales Ratio	0.24	0.25	0.22	0.22	0.22
Free Cash Flow Yield	3.24%	3.01%	3.58%	3.12%	3.45%
Valuation Ratios
Price-to-Earnings (P/E) Ratio	29.94	28.13	29.47	34.81	63.97
Price-to-Sales (P/S) Ratio	5.22	4.90	3.83	4.52	4.74
Price-to-Book (P/B) Ratio	6.38	5.91	4.98	5.38	5.67
Price-to-Free Cash Flow (P/FCF) Ratio	30.28	33.17	27.90	32.10	29.00
Price-to-Operating Cash Flow Ratio	21.30	19.73	17.11	20.37	21.40
Price-to-Earnings Growth (PEG) Ratio	3.27	0.58	2.17	0.41	0.02
Price-to-Fair Value	6.38	5.91	4.98	5.38	5.67
Enterprise Value Multiple	16.68	15.71	15.32	17.69	26.98
Enterprise Value	339.86B	311.51B	227.63B	233.39B	232.85B
EV to EBITDA	16.96	15.71	15.32	17.69	26.98
EV to Sales	5.71	5.30	4.30	5.01	5.26
EV to Free Cash Flow	33.16	35.93	31.29	35.54	32.18
EV to Operating Cash Flow	23.32	21.37	19.19	22.56	23.74
Tangible Book Value Per Share	-6.69	-6.69	-11.18	-12.04	-14.26
Shareholders’ Equity Per Share	31.38	31.40	26.31	25.06	23.93
Tax and Other Ratios
Effective Tax Rate	0.17	0.17	0.19	0.14	-0.32
Revenue Per Share	38.36	37.90	34.16	29.82	28.59
Net Income Per Share	6.69	6.60	4.44	3.88	2.12
Tax Burden	0.82	0.82	0.81	0.86	1.31
Interest Burden	0.88	0.88	0.86	0.86	0.74
Research & Development to Revenue	0.24	0.24	0.23	0.23	0.22
SG&A to Revenue	0.31	0.35	0.29	0.00	0.00
Stock-Based Compensation to Revenue	0.00	0.00	0.00	0.01	0.01
Income Quality	1.30	1.18	1.36	1.50	3.92

Currency in USD